Related Experiment Video
Updated: Mar 22, 2026
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumococcal Vaccination Strategies. An Update and Perspective
Andrew C Berical1, Drew Harris1, Charles S Dela Cruz1
1Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Pneumococcal vaccines, including PPV23 and PCV13, significantly reduce pneumococcal disease in all age groups. Ongoing research focuses on improving vaccine efficacy in aging populations and developing next-generation vaccines.
Area of Science:
- Immunology
- Infectious Diseases
- Vaccinology
Background:
- Streptococcus pneumoniae causes significant global disease, particularly pneumonia, disproportionately affecting young, elderly, and immunocompromised individuals.
- Chronic pulmonary disease increases susceptibility to pneumococcal infections.
- Advances in immunobiology and vaccination have improved prevention of invasive pneumococcal disease.
Purpose of the Study:
- To review current pneumococcal vaccine recommendations based on age and risk factors.
- To discuss challenges and future directions in pneumococcal vaccination.
Main Methods:
- Review of current literature on pneumococcal immunobiology and vaccine efficacy.
- Analysis of available pneumococcal vaccines: 23-valent pneumococcal polysaccharide vaccine (PPV23) and 13-valent pneumococcal protein-conjugate vaccine (PCV13).
Main Results:
- Infant vaccination with pneumococcal conjugate vaccines has decreased nasal carriage and disease rates across all age groups.
- Current recommendations outline specific vaccine indications and schedules for at-risk populations.
Conclusions:
- Continued efforts are needed to address waning immunity in the elderly and optimize the use of existing vaccines.
- Development of next-generation pneumococcal vaccines is crucial for sustained protection.
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation